AI app aims to ease chemo side effects for breast cancer patients

NCT ID NCT07273812

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests an Arabic-language AI mobile app designed to support women with breast cancer during chemotherapy. The app monitors symptoms, sends medication reminders, and provides educational content. Researchers will compare 130 women who use the app plus usual care to those who receive usual care alone, measuring changes in symptom burden, medication adherence, and quality of life over 12 weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
AI-based mobile application (AI Breast Cancer Support App)
What this could lead to
If it works, this app could help women with breast cancer better manage chemotherapy side effects, take their medications on time, and feel more informed about their treatment.
What could go wrong
This is a small, early-stage trial (130 participants) testing a support tool, not a treatment. The app is for education only and may not reduce symptoms or improve outcomes for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACCURACY OF AI APP are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Oncology Teaching Hospital-Medical City- Baghdad

    RECRUITING

    Baghdad, Iraq

More trials for these conditions

Other studies related to the condition(s) this trial covers.